Task: Answer Verification
Input (English): Question: Are beneficial effects of adjunctive aripiprazole in major depressive disorder dependent on antidepressant therapy history : a post hoc analysis of 3 randomized , double-blind , placebo-controlled trials?
Answer: Augmentation with aripiprazole, after either a between-class or within-class switch following initial ADT failure, is an effective option for patients with nonresponsive MDD. In contrast to current strategies employed in clinical practice, these results suggest that adjunctive aripiprazole is a logical strategy in patients unresponsive to ADT.
Output (English): no